Rockwell Medical, Inc. - Common Stock (RMTI)

Rockwell Medical is a biopharmaceutical company that focuses on developing and providing innovative treatments for patients with chronic kidney disease and end-stage renal disease

The company specializes in therapies aimed at addressing the complications associated with these conditions, particularly iron deficiency anemia. Rockwell Medical is engaged in the research and development of solutions that enhance the quality of life for patients undergoing dialysis and other renal care, aiming to improve patient outcomes through effective medical interventions.